CXCR2
CXCR2 (C-X-C motif chemokine receptor 2, also known as CD182, IL8RB and CMKAR2) is a G protein-coupled receptor for interleukin-8 on the cell surface. It guides neutrophil chemotaxis and migration towards sites of tissue injury and inflammation. Browse Assay Genie's current range of CXCR2 research reagents below, or read on for the biology behind the target.
CXCR2 is a receptor for interleukin-8 (IL-8), a powerful neutrophil chemotactic factor. When IL-8 binds, the receptor activates neutrophils through a G-protein that engages a phosphatidylinositol-calcium second messenger system. CXCR2 binds IL-8 with high affinity. It also binds CXCL3, GRO/MGSA (CXCL1) and NAP-2 with high affinity. In the homeostatic wound healing response to tissue injury, CXCR2 signals intravascular neutrophil chemotaxis to the injury site. This multistep cascade guides neutrophils to necrotic sites while avoiding collateral damage to healthy tissue.
The CXCR2 gene encodes a member of the G protein-coupled receptor 1 family, and the protein sits in the cell membrane. Alternatively spliced variants have been identified that encode the same protein. The gene lies in a cluster with IL8RA, which encodes another high-affinity IL-8 receptor, and with IL8RBP, a pseudogene of IL8RB. Mouse and rat both carry a Cxcr2 ortholog, which supports work in rodent models.
Beyond neutrophil recruitment, NCBI Gene summarises several further roles. CXCR2 has been shown to be a major component required for serum-dependent melanoma cell growth, through its binding of CXCL1. The angiogenic effects of IL-8 in intestinal microvascular endothelial cells are mediated by this receptor. Knockout studies in mice suggest that it controls the positioning of oligodendrocyte precursors in the developing spinal cord by arresting their migration. The receptor was formerly named interleukin 8 receptor, beta, and is also listed as chemokine (C-X-C motif) receptor 2. HGNC places it among CD molecules, interleukin receptors and C-X-C motif chemokine receptors.
CXCR2 mediates neutrophil migration to sites of inflammation, making it a focus for studies of leukocyte recruitment.
The receptor signals intravascular neutrophil chemotaxis to injury sites as part of the homeostatic wound healing response.
CXCR2 binding of CXCL1 is required for serum-dependent melanoma cell growth, linking the receptor to cancer biology.
CXCR2 mediates IL-8 angiogenic effects in intestinal endothelial cells and, in mice, positions oligodendrocyte precursors in developing spinal cord.
CXCR2 is a G protein-coupled receptor for IL-8 and other CXC chemokines, including CXCL1, CXCL3 and NAP-2. Ligand binding activates neutrophils through a G-protein and a phosphatidylinositol-calcium second messenger system, driving neutrophil migration to inflamed or injured tissue.
CXCR2 is also called CD182, IL8RB and CMKAR2. Earlier names include interleukin 8 receptor, beta, and chemokine (C-X-C motif) receptor 2. Alternatively spliced transcript variants have been reported, and they encode the same protein.
Mouse and rat both have a Cxcr2 ortholog. Mouse knockout studies point to a role in positioning oligodendrocyte precursors in the spinal cord. In humans, CXCR2 is linked to serum-dependent melanoma cell growth. Check the datasheet of any product for its validated reactivity.
Ligands, related chemokine receptors and neutrophil-recruitment targets connected to CXCR2 signalling.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P25025; product specifications from Assay Genie datasheets.